Commit To Buy MannKind Corp At $2.50, Earn 28%

Investors considering a purchase of MannKind Corp ( MNKD) shares, but cautious about paying the going market price of $6.72/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $2.50 strike, which has a bid at the time of this writing of 70 cents. Collecting that bid as the premium represents a 28% return against the $2.50 commitment, or a 16.9% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Selling a put does not give an investor access to MNKD's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $2.50 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless MannKind Corp sees its shares decline 62.9% and the contract is exercised (resulting in a cost basis of $1.80 per share before broker commissions, subtracting the 70 cents from $2.50), the only upside to the put seller is from collecting that premium for the 16.9% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for MannKind Corp, and highlighting in green where the $2.50 strike is located relative to that history:

If you liked this article you might like

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Mannkind in Free Fall After Changes to Insulin Product, Sales Force

Mannkind Stock Drops Following Changes to Its Insulin Product

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Insulin Drug Offers Hope for MannKind